Physician profile
Dima Sibai
NPI 1124307251
$1,552.43
in general payments reported to CMS, 2019-2025
11 companies · $229 in 2025
The $229 reported for 2025 was more than what 79% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $40.56 · 2021: $545 · 2022: $398 · 2023: $93.17 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.53 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolase, INC. | $494.60 | 2021 | |
| Align Technology, INC. | $410.56 | 2020-2025 | Invisalign, Itero Element 5d, Itero Element 2 |
| Peter Brasseler Holdings, LLC | $219.00 | 2019 | |
| Straumann USA LLC | $210.69 | 2020-2022 | |
| Biohorizons Implant Systems INC. | $76.59 | 2020-2025 | Biohorizons, Biohorizons Dental Implants |
| Nobel Biocare USA | $49.91 | 2019-2023 | Nobelactive |
| Philips North America LLC | $25.51 | 2021-2025 | Oral Health Care Undivided |
| Kerr Corporation | $22.77 | 2023 | Harmonize |
| Dentsply Sirona INC | $18.73 | 2021 | |
| Gc America INC. | $13.01 | 2021 | |
| Coltene Whaledent INC. | $11.06 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dima Sibai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.